News Press Releases

Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Emergent BioSolutions, Inc. Investors and Encourages Investors to Contact the Firm

EBS | August 11, 2016

Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Emergent BioSolutions, Inc. Investors and Encourages Investors to Contact the Firm

Glancy Prongay & Murray LLP (“GPM”) announces that a class action lawsuit has been filed on behalf of investors who purchased Emergent BioSolutions, Inc. (“Emergent” or the “Company”) (NYSE: EBS) securities between January 11, 2016 and June 21, 2016, inclusive (the “Class Period”). Emergent investors have until September 19, 2016 to file a lead plaintiff motion.

Investors suffering losses on their Emergent investments are encouraged to contact Lesley Portnoy of GPM to discuss their legal rights in this class action at 310-201-9150 or by email to shareholders@glancylaw.com.

Emergent is a specialty biopharmaceutical company that develops, manufactures and sells specialized products to healthcare providers and governments in the United States and internationally. One of the Company’s most lucrative contracts with the United States government is for the supply of a U.S. Strategic National Stockpile of anthrax vaccine.

According to the Complaint, Emergent issued false and misleading statements relating to the renewal of the U.S. government contract, including whether the Company misled investors regarding the U.S. government’s shift in focus from first-generation anthrax vaccines produced by Emergent, to next generation vaccines produced by other manufacturers. Following the news of the government’s change in policy, the Company’s shares fell sharply in value.

If you purchased shares of Emergent during the Class Period you may move the Court no later than September 19, 2016 to ask the Court to appoint you as lead plaintiff if you meet certain legal requirements. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at http://glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.